Results 61 to 70 of about 797 (106)

Picolinamide-functionalized macrocyclic chelators for ^203/212Pb theranostic radiotracers.

Inorg Chem Front
Osborne BE, Siakalli C, Brown RK, White AJP, Rocco C, Weiss D, Delgado-Pinar E, García-España E, Sosabowski JK, Ma MT, Long NJ.   +10 more
europepmc   +1 more source

Advancing Internal Dosimetry in Personalized Nuclear Medicine: Toward Optimized Radiopharmaceutical Use in Clinical Practice. [PDF]

Pharmaceuticals (Basel)
Alshehri AHD.
europepmc   +1 more source

Recommendations for Standardizing Nuclear Medicine Terminology and Data in the Era of Theranostics and Artificial Intelligence. [PDF]

J Nucl Med
Bradshaw TJ, Brosch-Lenz J, Uribe C, Karakatsanis N, Bruce R, Strigari L, Jha A, Dutta J, Schwartz J, El Fakhri G, Avval A, Rahmim A, Saboury B.   +12 more
europepmc   +1 more source

Role of Radioiodine in Cancer Therapy: A Review of the Design and Challenges in Selecting Radioligands from Natural Sources. [PDF]

Drug Des Devel Ther
Fakih TM, Novitasari D, Syaifudin M, Meiyanto E, Astirin OP, Mohd Gazzali A, Muchtaridi M.   +6 more
europepmc   +1 more source

The Impact of the COVID-19 Pandemic on a Nuclear Medicine Department in Riyadh, Saudi Arabia. [PDF]

J Multidiscip Healthc
Jambi LK, Almutairi F, Alotaibi AS, Alshaya AK, Alharbi OM, Alqahtani AO, Alyami W, Alyafei HM, Alhawas A.   +8 more
europepmc   +1 more source

Next-Gen ¹⁸F-Relay Reagent: Optimising [¹⁸F]Ethanesulfonyl Fluoride. [PDF]

Int J Mol Sci
Aulsebrook ML, Pascali G, Tuck KL, Rashid PT, Kubeil M, Hagemeyer CE, Pietzsch J, Laube M.   +7 more
europepmc   +1 more source

Redox-driven speciation and colloid formation contribute the in vivo chemistry and organ deposition of Astatine-211. [PDF]

EJNMMI Radiopharm Chem
Dong X, Li J, Chen M, Zhang K, Zhang X, Shan F, Xue S, Li X, Zhang L, Cai H, Liu J, Li Q.   +11 more
europepmc   +1 more source

Radionuclide-Dependent Stimulation of Antitumor Immunity in GD2-Targeted Radiopharmaceutical Therapy Combined with Immune Checkpoint Inhibitors. [PDF]

Radiation (Basel)
Lilieholm C, Zaborek J, Kwon O, Adeniyi AO, Kerr CP, Rojas HC, Idrissou MB, Ferreira CA, Clark PA, Jin WJ, Grudzinski JJ, Erbe AK, Aluicio-Sarduy E, Kanagasundaram T, Wilson JJ, Engle JW, Hernandez R, Bednarz B, Morris ZS, Weichert JP.   +19 more
europepmc   +1 more source

Model-Informed Radiopharmaceutical Therapy Optimization: A Study on the Impact of PBPK Model Parameters on Physical, Biological, and Statistical Measures in ¹⁷⁷Lu-PSMA Therapy. [PDF]

Cancers (Basel)
Abdollahi H, Fele-Paranj A, Rahmim A.
europepmc   +1 more source

Radiotheranostics in Low- and Middle-Income Countries: Challenges, Practice, and Prospects. [PDF]

World J Nucl Med
Lawal IO, Ndlovu H, Kabunda J, Mokoala KM, Sathekge MM.   +4 more
europepmc   +1 more source